Clinics in Liver Disease

Papers
(The TQCC of Clinics in Liver Disease is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Navigating the Management of Hepatocellular Carcinoma340
Forthcoming Issues48
Copyright38
Contributors32
Forthcoming Issues30
Forthcoming Issues30
Forthcoming Issues29
Recurrent and De Novo Liver Disease After Liver Transplantation29
The Role of Liver Transplantation in Hepatocellular Carcinoma28
Contributors25
Forthcoming Issues23
Artificial Intelligence and Machine Learning Applications in Liver Disease23
Endoscopic Ultrasound-Guided Liver Biopsy22
Artificial Intelligence, Large Language Models, and Digital Health in the Management of Alcohol-Associated Liver Disease20
Contents19
Preface18
Through the Scope Hepatobiliary Interventions in Patients with Liver Diseases: Minimizing Risks and Improving Outcomes18
Management of Biliary Complications in Liver Transplant Recipients17
What is the Path Forward to Treat Hepatitis Delta Virus?16
Advances in Viral Hepatitis B and D: Moving Toward the Goals of Elimination16
Overview of New Targets for Hepatitis B Virus16
Clinical Vignettes Illustrating the Spectrum of Hepatocellular Carcinoma Presentation and Treatment15
Pathogenesis of Alcohol-Associated Liver Disease15
Preface15
Evaluation and Management of Pruritus in Primary Biliary Cholangitis14
Consultations in Liver Disease14
The Use of Hepatitis C Virus–Positive Organs in Hepatitis C Virus–Negative Recipients14
Nonalcoholic Fatty Liver Disease in Latin America and Australia14
Primary Biliary Cholangitis13
Portal Hypertension and its Complications13
Alcohol-Associated Liver Disease12
Primary Sclerosing Cholangitis12
Contributors12
Biliary Atresia in Children12
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease11
Minimal Hepatic Encephalopathy10
Recent Advances in Primary Biliary Cholangitis Treatment10
Pharmacologic Management of Hepatic Encephalopathy10
Substance Use Disorders and Interprofessional Management in the Pre and Post Liver Transplant Settings10
Targeting Hepatitis B Virus DNA Using Designer Gene Editors10
Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis9
The Liver in Diabetes and Metabolic Syndrome8
Copyright8
Beyond the Liver8
Hepatocellular Carcinoma8
Copyright8
The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney Disease8
Chronic Hepatitis B8
Current and Next-Generation Therapeutics in Hepatology8
The Liver in Hematologic Malignancies8
Hepatorenal Syndrome8
Contents8
Hepatitis B and C in Children8
Navigating Hepatocellular Carcinoma8
Novel Therapies in Primary Biliary Cholangitis8
Role of Endoscopic Retrograde Cholangiopancreatography in the Diagnosis and Management of Cholestatic Liver Diseases8
Noninvasive Fibrosis Testing in Chronic Liver Disease Including Caveats8
Prognostic Scoring Systems in Primary Biliary Cholangitis8
Treatment of Primary Sclerosing Cholangitis Including Transplantation8
Improving Diagnostic Yield in Indeterminate Biliary Strictures8
Forthcoming Issues8
Overview of Progressive Familial Intrahepatic Cholestasis7
Amyloidosis and the Liver7
Kidney Allocation Issues in Liver Transplantation Candidates with Chronic Kidney Disease and Severe Kidney Liver Injury7
Alagille Syndrome7
Preventing Readmissions for Hepatic Encephalopathy7
Hepatic Encephalopathy7
Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis7
What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?7
Primary Biliary Cholangitis7
Contents7
Portal Hypertension and its Complications: A Guided Tour of the Post–Baveno 7 Landscape7
Genetics of Primary Biliary Cholangitis7
The Evolving Role of Therapeutic Endoscopy in Patients with Chronic Liver Diseases7
Renal Insufficiency in Patients with Cirrhosis6
Contributors6
Chronic Hepatitis B Virus and Hepatitis D Virus6
Hepatic Encephalopathy in Acute-on-Chronic Liver Failure6
Genetic Markers Predisposing to Nonalcoholic Steatohepatitis6
Systemic Complications of Primary Biliary Cholangitis6
State of the Art6
Phenotypes of Primary Sclerosing Cholangitis and Differential Diagnosis6
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease6
0.060617923736572